Article Text

Download PDFPDF
The role of risedronate in osteopenia in Crohn's disease
  1. Alice Buchan,
  2. Ari Manuel
  1. Correspondence to Alice Buchan, Medical student, University of Oxford, Balliol College, Oxford OX1 3BJ, UK; alice.buchan{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We read with great interest van Bodegraven et al's1 paper about the treatment of osteopenia in patients with Crohn's disease. They have identified an evidence gap, as many studies of interventions to treat osteoporosis and prevent bone loss have been conducted on older and primarily female patients. In contrast, both male and female patients with Crohn's disease may develop osteopenia and osteoporosis at a younger age. …

View Full Text


  • Contributors AB wrote the letter, with assistance from AM. AB made the revisions suggested.

  • Competing interests None.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles